Compare Enveric Biosciences Inc (ENVB) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs MobilEye Global Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while MobilEye Global Inc trades at $9.16 (market cap $7.94B). The key difference: MobilEye Global Inc is far larger — about 1492.5× Enveric Biosciences Inc's market cap, and MobilEye Global Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | MBLY | |
|---|---|---|
Market Cap | $5.32M | $7.94B |
Sector | Health | Technology |
52-Week High | $17.40 | $16.27 |
52-Week Low | $1.28 | $6.56 |
Enterprise Value | $408.82K | $6.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mobileye (MBLY) trades at $9.06, down 10.21% over 24 hours, reflecting market volatility amid mixed signals. The stock shows a neutral technical stance with key support at $9 and resistance at $10. Fundamentally, the company reported a net loss of -$392M in 2025 despite revenue of $1.89B, with a negative net income margin of -203.97% in 2026 projections. Recent news highlights the planned 2027 U.S. robotaxi launch, signaling strategic expansion beyond its ADAS supplier role.
The outlook hinges on execution of the robotaxi initiative, offering growth potential but carrying significant execution and competitive risks. Analyst consensus is bullish with a $10.71 price target, though profitability challenges and high valuation multiples like EV/EBITDA of 73.31 pose near-term headwinds for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
